| 发明名称 |
COMBINATION OF DOPAMINE AGONISTS PLUS FIRST PHASE INSULIN SECRETAGOUGES FOR THE TREATMENT OF METABOLIC DISORDERS |
| 摘要 |
<p>The present invention is directed to a method of treating a metabolic disorder or key elements of a metabolic disorder such method comprising the use of an agent(s) that increases central dopaminergic activity plus a first-phase insulin secretagouge.</p> |
| 申请公布号 |
EP2437732(A4) |
申请公布日期 |
2012.10.31 |
| 申请号 |
EP20100784223 |
申请日期 |
2010.06.07 |
| 申请人 |
VEROSCIENCE LLC |
发明人 |
CINCOTTA, ANTHONY, H. |
| 分类号 |
A61K9/22;A61K31/165;A61K31/195;A61K31/4453;A61K31/48;A61K31/4985;A61K45/06;A61P3/04;A61P3/10 |
主分类号 |
A61K9/22 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
